Elizabeth Eve Slater Net Worth & Insider Trades
Elizabeth Eve Slater - Director, Vertex Pharmaceuticals Inc / Ma
What is Elizabeth Eve Slater's Net Worth?
The current estimated net worth of Vertex Pharmaceuticals Inc / Ma's Director, Elizabeth Eve Slater, is estimated to be about $538.19K . Elizabeth Eve Slater owns about 1,105 units of Vertex Pharmaceuticals Inc / Ma common stock. In the last 3 years at Vertex Pharmaceuticals Inc / Ma, Elizabeth Eve Slater has sold an estimated value of $304.2K worth.
What is Elizabeth Eve Slater's Past Insider Trading?
Elizabeth Eve Slater's largest purchase order was 10,000 units , worth over $133.2K on May 30, 2007. Elizabeth Eve Slater's largest sale order was 10,000 units , worth over $304.2K on May 30, 2007. In total, Elizabeth Eve Slater has made about 6 transactions over 3 years of their time at Vertex Pharmaceuticals Inc / Ma. Elizabeth Eve Slater usually trades in June, with the busiest year in 2007 and 2006.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Elizabeth Eve Slater
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Elizabeth Eve Slater's' Mailing Address?
- Mailing address is C/o Vertex Pharmaceuticals Incorporated 130 Waverly Street, Attn: General Counse Cambridge MA 02139 MA
What are Vertex Pharmaceuticals Inc / Ma's Past Insider Trades?
Vertex Pharmaceuticals Inc / Ma's most recent insider trade came on November 21, 2023 by Charles Wagner Jr who sold 3,000 units worth $1.05M . In the last 20 years, insiders at Vertex Pharmaceuticals Inc / Ma have sold an estimated value of $1.81B and bought an estimated value of $541.77M worth of shares. Insider trading is most common in February, with the busiest year in 2015. The most active traders at the company are Joshua Boger, Director, Paul Silva, SVP & Chief Accounting Officer, and Amit Sachdev, EVP Chief Patient & Ext Af Off .
VERTEX PHARMACEUTICALS INC / MA Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |